In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
about
The various aspects of genetic and epigenetic toxicology: testing methods and clinical applicationsIdentification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer.Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
P2860
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In silico prediction and in vi ...... er drug for bladder carcinoma.
@en
type
label
In silico prediction and in vi ...... er drug for bladder carcinoma.
@en
prefLabel
In silico prediction and in vi ...... er drug for bladder carcinoma.
@en
P2093
P2860
P356
P1476
In silico prediction and in vi ...... er drug for bladder carcinoma.
@en
P2093
Hongjian Li
Hsiang-Fu Kung
Kwong-Sak Leung
Man-Hon Wong
Marie Chia-Mi Lin
Xi-Nan Shi
P2860
P304
P356
10.1111/CBDD.12872
P577
2016-09-24T00:00:00Z